Karl-Norbert Klotz

Discovery of Novel Adenosine Receptor Antagonists through a Combined Structure- and Ligand-Based Approach Followed by Molecular Dynamics Investigation of Ligand Binding Mode

Antonios Kolocouris, Gabriella Ortore, Marino Convertino, 2018, J. Chem. Inf. Model..

8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) — a selective high affinity antagonist radioligand for A1 adenosine receptors

Martin J. Lohse, Martin Reddington, Ray A. Olsson, 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.

The application of a 3D-QSAR (autoMEP/PLS) approach as an efficient pharmacodynamic-driven filtering method for small-sized virtual library: application to a lead optimization of a human A3 adenosine receptor antagonist.

Magdalena Bacilieri, Barbara Cacciari, Giampiero Spalluto, 2006, Bioorganic & medicinal chemistry.

Analysis of receptor oligomerization by FRAP microscopy

Stefan Engelhardt, Karl-Norbert Klotz, K. Klotz, 2009, Nature Methods.

5'-C-Ethyl-tetrazolyl-N(6)-substituted adenosine and 2-chloro-adenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists.

Riccardo Petrelli, Ettore Novellino, Antonio Lavecchia, 2015, Journal of medicinal chemistry.

Adenosine A1 Receptor-Mediated Activation of Phospholipase C in Cultured Astrocytes Depends on the Level of Receptor Expression

Knut Biber, Karl-Norbert Klotz, K. Klotz, 1997, The Journal of Neuroscience.

Synthesis, biological evaluation, and molecular modeling of ribose-modified adenosine analogues as adenosine receptor agonists.

Riccardo Petrelli, Barbara Costa, Ettore Novellino, 2005, Journal of medicinal chemistry.

Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonists.

Barbara Cacciari, Giampiero Spalluto, Tatiana Da Ros, 2002, Journal of medicinal chemistry.